The Phase Ib/IIa randomized, double-blind, placebo-controlled multicenter RCT (NCT04353791) enrolled 32 patients with moderate to severe UC across 16 locations in Spain and Ukraine, randomizing 24 subjects to receive Oncostellae and 8 to placebo for 28 days
Across regions, FDAs enforcement posture operationalises 211.68(b) as a data integrity statute aligned to ALCOA+ expectations (Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, Available)
Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine
From your initial consultation to regular check-ins, our team is here to monitor your health, celebrate your victories, and provide the expert guidance you need to succeed
All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) at the Center for Experimental Animals of Third Military Medical University